Thanks for your question Robert. Look obviously capacity we look across our entire network and in the US across 2,600 clinics. Obviously our utilization has been under what we would have liked it to have been -- if I recall, Bill said we were around 60% at the moment when we gave Capital Markets Day update a couple of weeks ago. As you know we have 3% assumed in for this year the MedPAC report that preliminary and kind of feeds into the preliminary PPS suggested a full increase but we'll see how that plays ...

Thank you. My question was just on -- just in terms of the clinic closures you're doing, just if you could give us some sort of idea of the or sort of share a view over an installed base or the overall kind of clinic number that you're taking out? And is there some sort of ballpark figure per clinic or is it too big of variability as you take this out to get some idea of how much cost would come back? Helen Giza And then on your second question, in terms of ROIC, I think that was always kind of part of a po ...

© Copyright | --- | --- | --- | --- | |--------------------------------------------------------------------------|-------|-------|-------| | | | | | | | | | | | | | | | | Q4 2022 Conference Call February 22, 2023 Helen Giza, CEO & Chair of the | | | | | Management Board | | | | | | | | | Implementation of measures as presented herein may be subject to information & consultation procedures with works councils and other employee representative bodies, as per local laws and practice. Consultation procedures ma ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 Table of Contents or Date of event requiring this shell company report Commission file number 001-32749 FRESENIUS MEDICAL CARE AG & Co. KGaA (Exact name of Registrant as specified in its charter) FRESENIUS MEDICAL CARE AG & Co. KGaA (Translation of Registrant's name into English) Germany (Jurisdiction of incorporation or ...

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Q3 2022 Earnings Conference Call October 31, 2022 10:30 AM ET Company Participants Dominik Heger - Head of Investor Relations Carla Kriwet - Chief Executive Officer & Chair of the Management Board Helen Giza - Deputy Chief Executive Officer, Chief Financial Officer & Chief Transformation Officer Conference Call Participants Tom Jones - Berenberg Graham Doyle - UBS James Vane-Tempest - Jefferies Hassan Al-Wakeel - Barclays Veronika Dubajova - Citi Oliver Metzge ...

Q3 2022 Analyst Presentation Dr. Carla Kriwet, CEO Helen Giza, Deputy CEO & CFO © Copyright Safe harbor statement: This presentation includes certain forward-looking statements within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Act of 1934, as amended. Forward-looking statements are inherently subject to risks and uncertainties, many of which cannot be predicted with accuracy or might not even be anticipated. The Company has based these f ...

Fresenius Medical Care AG & Co. KGaA. (NYSE:FMS) Q4 2021 Earnings Conference Call February 22, 2022 9:00 AM ET Company Participants Dominik Heger - Head of Investor Relations Rice Powell - Chief Executive Officer & Chairman of the Management Board Helen Giza - Chief Financial Officer & Chief Transformation Officer, FME25 Conference Call Participants Veronika Dubajova - Goldman Sachs Tom Jones - Berenberg Lisa Clive - Bernstein Oliver Metzger - Oddo BHF Patrick Wood - Bank of America Falko Friedrichs - Deuts ...

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Q3 2021 Earnings Conference Call November 2, 2021 10:30 AM ET Company Participants Dominik Heger - Head of Investor Relations Rice Powell - Chief Executive Officer & Chairman of the Management Board Helen Giza - Chief Financial Officer & Chief Transformation Officer, FME25 Conference Call Participants Oliver Metzger - Oddo BHF Veronika Dubajova - Goldman Sachs Lisa Clive - Bernstein Tom Jones - Berenberg Patrick Wood - Bank of America David Adlington - JPMorga ...

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Q2 2021 Earnings Conference Call July 30, 2021 9:30 AM ET Company Participants Dominik Heger - Head of Investor Relations Rice Powell - Chief Executive Officer & Chairman of the Management Board Helen Giza - Chief Financial Officer Conference Call Participants Tom Jones - Berenberg Veronika Dubajova - Goldman Sachs Oliver Metzger - Commerzbank Michael Jungling - Morgan Stanley David Adlington - JPMorgan Falko Friedrichs - Deutsche Bank James Vane-Tempest - Jef ...

| --- | --- | --- | |-------------------------------------------------------|-------|-------| | | | | | Q2 2021 CONFERENCE CALL | | | | JULY 30, 2021 Rice Powell – CEO Helen Giza – CFO | | | © Copyright | --- | --- | --- | --- | |------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ...